Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Accumulated Expenses (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Accumulated Expenses for 4 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 59.26% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, up 59.26% year-over-year, with the annual reading at $4.2 million for FY2025, 59.26% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $4.2 million at Orchestra BioMed Holdings, up from $1.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $5.1 million in Q4 2023, with the low at $202931.0 in Q1 2022.
  • Average Accumulated Expenses over 4 years is $2.0 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses soared 347.94% in 2023, then plummeted 49.27% in 2024.
  • Over 4 years, Accumulated Expenses stood at $2.5 million in 2022, then soared by 107.62% to $5.1 million in 2023, then crashed by 49.27% to $2.6 million in 2024, then surged by 59.26% to $4.2 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $4.2 million, $1.8 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.